Ausgabe 10/2013
Inhalt (22 Artikel)
Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice
Nayoun Kim, Keon-Il Im, Jung-Yeon Lim, Eun-Joo Jeon, Young-Sun Nam, Eun-Jung Kim, Seok-Goo Cho
De novo AML patients with favourable–intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened “GO question”
Marino Clavio, Fabio Cruciani, Paola Minetto, Fabio Guolo, Filippo Ballerini, Carlo Marani, Enrico De Astis, Sara Aquino, Micaela Bergamaschi, Laura Mitscheunig, Raffaella Grasso, Nicoletta Colombo, Chiara Ghiggi, Davide Lovera, Giordana Pastori, Daniele Avenoso, Maurizio Miglino, Marco Gobbi
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia
Saquib Ashraf, Nélida I. Noguera, Jonny Di Giandomenico, Serena Zaza, Syed Khizer Hasan, Francesco Lo-Coco
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability
Florian Nolte, Michelle Giehl, Wiltrud Haass, Verena Nowak, Christiane Schumann, Daniel Nowak, Maximillian Mossner, Henning D. Popp, Torsten J. Schulze, Stefan Klein, Wolfgang Seifarth, Wolf-Karsten Hofmann, Alice Fabarius
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes
Bin Fu, Chi Young Ok, Maitrayee Goswami, Wei Xei, Jesse M. Jaso, Tariq Muzzafar, Carlos Bueso-Ramos, Srdan Verstovsek, Guillermo Garcia-Manero, L. Jeffrey Medeiros, Sa A. Wang
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
Paul La Rosée, Philippe Martiat, Armin Leitner, Thomas Klag, Martin C. Müller, Philipp Erben, Thomas Schenk, Susanne Saussele, Andreas Hochhaus
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab
Zi-Zhen Xu, Zu-Guang Xia, Ai-Hua Wang, Wen-Fang Wang, Zhi-Yin Liu, Li-Yun Chen, Jun-Min Li
Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin’s lymphoma
Ahmed M. L. Bedewy, Maha M. Adel Elgammal, Magdy M. L. Bedewy, Shereen M. EL-Maghraby
The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin’s lymphoma patients
Byeong Seok Sohn, Dok Hyun Yoon, Kyu Pyo Kim, Shin Kim, Kyung Min Lee, Jung Sun Park, Dae Ho Lee, Jin-Sook Ryu, Jooryung Huh, Il Ki Hong, Cheolwon Suh
Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia
Johanna Tischer, Hans Joachim Stemmler, Nicole Engel, Max Hubmann, Susanne Fritsch, Dusan Prevalsek, Christoph Schulz, Anna K. Zoellner, Veit Bücklein, Wolfgang Hill, Georg Ledderose, Andreas Hausmann
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia
Dominik Schneidawind, Birgit Federmann, Christoph Faul, Wichard Vogel, Lothar Kanz, Wolfgang Andreas Bethge
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
Marta Krejci, Michael Doubek, Jaroslav Dusek, Yvona Brychtova, Zdenek Racil, Milan Navratil, Miroslav Tomiska, Ondrej Horky, Sarka Pospisilova, Jiri Mayer
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP)
F. Carraro, M. P. Cicalese, S. Cesaro, R. De Santis, G. Zanazzo, A. Tornesello, P. Giordano, A. Bergadano, M. Giacchino
Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation
Massimo Breccia, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine
Yoshitaka Nishikawa, Shinya Okuda, Chiaki Takebayashi, Tetsuya Tanimoto, Masahiro Kami, Kazuhiko Kobayashi
Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis
Min Ju Choi, Do-Young Kim, Jin Seok Kim, Hyunki Kim, Sung Bin Cho
Disseminated plasmacytomas in multiple myeloma: atypical presentations on multimodality images, emphasized on PET/CT
Jingwei Yi, Shengjun Wang, Shirong Ma, Zhiyong Quan, Xiaohu Zhao, Zhiping Yang, Jing Wang
Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab
Chi-Chiu So, William W. L. Choi, Yok-Lam Kwong
Optic neuritis preceding progressive outer retinal necrosis in an immunocompromised patient after allogeneic stem cell transplantation
Amit Patel, Eduardo Olavarria
Necrotic and ulcerated cutaneous and mucosal leukemia cutis in AML6
Claude Bachmeyer, Marc Buffet, Philippe Moguelet, Albert Najman, Sélim Aractingi
Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma
Jan Cerny, Hongbo Yu, Patricia M. Miron
Life-threatening bleeding tendency provoked by an acquired isolated factor X deficiency associated with respiratory infection
L. Coucke, S. Trenson, D. Deeren, I. Van haute, K. Devreese